Mar 27, 2024 Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
Sep 26, 2023 Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation
